Eye movement desensitization and reprocessing for depression: a systematic review and meta-analysis.

Sara Carletto, Francesca Malandrone, Paola Berchialla, Francesco Oliva, Nicoletta Colombi, Michael Hase, Arne Hofmann, Luca Ostacoli
Author Information
  1. Sara Carletto: Department of Neurosciences, University of Turin, Turin, Italy.
  2. Francesca Malandrone: Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. ORCID
  3. Paola Berchialla: Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. ORCID
  4. Francesco Oliva: Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. ORCID
  5. Nicoletta Colombi: Biblioteca Federata di Medicina "Ferdinando Rossi", University of Turin, Turin, Italy. ORCID
  6. Michael Hase: Lüneburg Centre for Stress Medicine, Lüneburg, Germany.
  7. Arne Hofmann: EMDR-Institute, Bergisch Gladbach, Germany.
  8. Luca Ostacoli: Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. ORCID

Abstract

: In recent years, eye movement desensitization and reprocessing (EMDR) has been applied to different psychiatric conditions beyond post-traumatic stress disorder (PTSD), and an increasing number of studies have evaluated its effect on depression. To date, no quantitative synthesis of the efficacy of EMDR on depression has been conducted. : To meta-analytically review the studies on EMDR for depression as the primary target for treatment. : Studies with a controlled design evaluating the effect of EMDR on depression were searched on six electronic databases (PubMed, Embase, CINAHL, PsycINFO, Cochrane database, and Francine Shapiro Library) and then selected by two independent reviewers. A systematic review and meta-analysis was conducted. : Eleven studies were included for qualitative synthesis. Nine studies were included in the meta-analysis, involving 373 participants. The overall effect size of EMDR for depressive symptoms is large ( = 9, Hedges' = - 1.07; 95%CI [-1.66; - 0.48]), with high heterogeneity (  = 84%), and corresponds to a 'number needed to treat' of 1.8. At follow-up (range 3-6 months), the effect remains significant but moderate ( = 3, Hedges' = - 0.62; 95%CI [-0.97; - 0.28];  = 0%). The effect of EMDR compared with active controls is also moderate ( = 7, = - 0.68; 95%CI [-0.92; - 0.43];  = 0%). No publication bias was found, although the results are limited by the small number and poor methodological quality of the included studies. : Review findings suggest that EMDR may be considered an effective treatment for improving symptoms of depression, with effects comparable to other active treatments. However, findings need to be interpreted in light of the limited number of the studies and their quality. Further research is required to understand the longer-term of effects EMDR in treating depression and preventing depression relapse. : PROSPERO (CRD42018090086).

Keywords

References

  1. Control Clin Trials. 1986 Sep;7(3):177-88 [PMID: 3802833]
  2. Clin Psychol Rev. 2010 Mar;30(2):217-37 [PMID: 20015584]
  3. Cogn Behav Ther. 2020 May;49(3):165-180 [PMID: 32043428]
  4. Front Psychol. 2017 Sep 26;8:1668 [PMID: 29018388]
  5. J Affect Disord. 2019 Jan 1;242:195-210 [PMID: 30195173]
  6. Psychiatry Investig. 2008 Mar;5(1):60-5 [PMID: 20046410]
  7. BMJ. 2019 Aug 28;366:l4898 [PMID: 31462531]
  8. Front Psychol. 2018 Aug 14;9:1384 [PMID: 30186192]
  9. Child Abuse Negl. 2009 Jan;33(1):59-68 [PMID: 19167067]
  10. Front Psychol. 2018 Feb 13;9:74 [PMID: 29487548]
  11. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5335-40 [PMID: 9560276]
  12. Child Abuse Negl. 2014 Oct;38(10):1590-8 [PMID: 25035171]
  13. Br J Psychiatry. 2017 Feb;210(2):96-104 [PMID: 27908895]
  14. ANZ J Surg. 2003 Sep;73(9):712-6 [PMID: 12956787]
  15. Psychol Med. 2019 Jun;49(8):1266-1274 [PMID: 30688184]
  16. Cochrane Database Syst Rev. 2013 Dec 13;(12):CD003388 [PMID: 24338345]
  17. J Couns Psychol. 2013 Oct;60(4):593-600 [PMID: 23815633]
  18. J Affect Disord. 2021 Mar 1;282:340-347 [PMID: 33421861]
  19. J Affect Disord. 2009 Oct;117 Suppl 1:S15-25 [PMID: 19682749]
  20. Psychol Psychother. 2021 Mar;94(1):81-100 [PMID: 31965734]
  21. Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14293-6 [PMID: 14615578]
  22. Prog Brain Res. 2000;122:81-103 [PMID: 10737052]
  23. J Neuropsychiatry Clin Neurosci. 2008 Summer;20(3):292-301 [PMID: 18806232]
  24. Glob J Health Sci. 2015 Apr 19;7(6):258-62 [PMID: 26153191]
  25. Kaohsiung J Med Sci. 2015 Jul;31(7):363-9 [PMID: 26162817]
  26. Front Psychol. 2017 Oct 10;8:1750 [PMID: 29066991]
  27. Lancet. 2018 Nov 10;392(10159):1789-1858 [PMID: 30496104]
  28. PLoS One. 2019 Feb 14;14(2):e0211882 [PMID: 30763360]
  29. Clin Psychol Rev. 2014 Aug;34(6):506-17 [PMID: 25189522]
  30. J Affect Disord. 2013 Jul;149(1-3):1-13 [PMID: 23528438]
  31. J Consult Clin Psychol. 2008 Dec;76(6):909-22 [PMID: 19045960]
  32. Psychol Med. 2006 Mar;36(3):299-312 [PMID: 16472412]
  33. J Consult Clin Psychol. 2007 Jun;75(3):475-88 [PMID: 17563164]
  34. Brain Res. 2002 Sep 20;950(1-2):52-63 [PMID: 12231228]
  35. JAMA Psychiatry. 2020 Mar 1;77(3):294-302 [PMID: 31799994]
  36. BMJ. 1997 Sep 13;315(7109):629-34 [PMID: 9310563]
  37. Eur Psychiatry. 2015 Sep;30(6):665-80 [PMID: 26078093]
  38. BMC Psychiatry. 2016 Aug 19;16:295 [PMID: 27543114]
  39. Science. 1997 Sep 12;277(5332):1659-62 [PMID: 9287218]
  40. Eur J Psychotraumatol. 2019 Nov 8;10(1):1682931 [PMID: 31762948]
  41. Brain Behav. 2015 Jun;5(6):e00342 [PMID: 26085967]
  42. Neurosci Biobehav Rev. 2008;32(1):1-19 [PMID: 17570526]
  43. Res Synth Methods. 2012 Sep;3(3):214-23 [PMID: 26062164]
  44. Brain Res Mol Brain Res. 1993 May;18(3):195-200 [PMID: 8497182]
  45. Front Psychol. 2017 Sep 21;8:1578 [PMID: 28983265]
  46. J Clin Psychol. 2018 Nov;74(11):1924-1937 [PMID: 30091140]
  47. Dev Neurosci. 1996;18(1-2):49-72 [PMID: 8840086]
  48. Curr Psychiatry Rep. 2019 Nov 23;21(12):129 [PMID: 31760505]
  49. Clin Psychol Rev. 2006 Oct;26(6):719-45 [PMID: 16111794]
  50. Clin Psychol Rev. 2017 Nov;57:141-163 [PMID: 28941927]
  51. Am J Psychiatry. 2012 Feb;169(2):141-51 [PMID: 22420036]
  52. Transl Psychiatry. 2016 May 03;6:e799 [PMID: 27138798]
  53. PLoS Med. 2013;10(5):e1001454 [PMID: 23723742]
  54. Psychiatry Res. 2019 Mar;273:567-574 [PMID: 30711853]
  55. BMC Psychiatry. 2017 Mar 28;17(1):113 [PMID: 28351403]
  56. Trauma Violence Abuse. 2004 Jul;5(3):285-300 [PMID: 15189638]
  57. Biol Psychiatry. 2006 Jun 1;59(11):990-6 [PMID: 16368078]
  58. Child Abuse Negl. 2020 Apr;102:104361 [PMID: 32062423]
  59. J Evid Based Med. 2015 Feb;8(1):2-10 [PMID: 25594108]
  60. Int J Surg. 2010;8(5):336-41 [PMID: 20171303]

Word Cloud

Created with Highcharts 10.0.0EMDRdepression:studies-effect0reviewmeta-analysismovementdesensitizationreprocessingnumbersystematicincluded=95%CIsynthesisconductedtreatmentsymptomsHedges'1moderate[-0 = 0%activelimitedqualityfindingseffectsEyerecentyearseyeapplieddifferentpsychiatricconditionsbeyondpost-traumaticstressdisorderPTSDincreasingevaluateddatequantitativeefficacymeta-analyticallyprimarytargetStudiescontrolleddesignevaluatingsearchedsixelectronicdatabasesPubMedEmbaseCINAHLPsycINFOCochranedatabaseFrancineShapiroLibraryselectedtwoindependentreviewersElevenqualitativeNineinvolving373participantsoverallsizedepressivelarge= 907[-16648]highheterogeneity = 84%corresponds'numberneededtreat'8follow-uprange3-6 monthsremainssignificant= 3629728]comparedcontrolsalso= 7689243]publicationbiasfoundalthoughresultssmallpoormethodologicalReviewsuggestmayconsideredeffectiveimprovingcomparabletreatmentsHoweverneedinterpretedlightresearchrequiredunderstandlonger-termtreatingpreventingrelapsePROSPEROCRD42018090086depression:psychotherapytrauma

Similar Articles

Cited By